Inhibitors of hydroxymethylglutaryl coenzyme A reductase for treating hypercholesterolaemia.
作者信息
Barth J D, Kruisbrink O A, Van Dijk A L
机构信息
Department of Cardiology, Radboud University Hospital, Nijmegen, The Netherlands.
出版信息
BMJ. 1990 Sep 29;301(6753):669. doi: 10.1136/bmj.301.6753.669-a.
Abstract
摘要
相似文献
1
Inhibitors of hydroxymethylglutaryl coenzyme A reductase for treating hypercholesterolaemia.用于治疗高胆固醇血症的羟甲基戊二酰辅酶A还原酶抑制剂。
BMJ. 1990 Sep 29;301(6753):669. doi: 10.1136/bmj.301.6753.669-a.
2
An overview: long-term tolerability of lovastatin and simvastatin.
Zhonghua Yi Xue Za Zhi (Taipei). 1992 Feb;49(2):138-9.
3
Worldwide experience with simvastatin/lovastatin.
Eur Heart J. 1992 Jul;13 Suppl B:21-2. doi: 10.1093/eurheartj/13.suppl_b.21.
4
Depressive symptoms and cholesterol-lowering drugs.
Lancet. 1993 Jan 9;341(8837):114. doi: 10.1016/0140-6736(93)92591-g.
5
[Simvastatin in the treatment of hypercholesterolemia].[辛伐他汀治疗高胆固醇血症]
Clin Ter. 1991 Jun 15;137(5):333-7.
6
Long-term clinical tolerance of lovastatin and simvastatin.
Cardiology. 1990;77 Suppl 4:58-65. doi: 10.1159/000174684.
7
Statin therapy and CHD.
Lancet. 1996 Jan 13;347(8994):128. doi: 10.1016/s0140-6736(96)90258-5.
8
Lipid control with low-dosage simvastatin in patients with moderate hypercholesterolaemia. An Italian multicentre double-blind placebo-controlled study.
Eur Heart J. 1992 Jul;13 Suppl B:11-6. doi: 10.1093/eurheartj/13.suppl_b.11.
9
Proteinuria as complication of simvastatin treatment.
Lancet. 1990 Dec 8;336(8728):1453. doi: 10.1016/0140-6736(90)93164-k.
10
Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.HMG-CoA还原酶抑制剂单药治疗原发性高胆固醇血症的安全性和有效性的比较评估。
Ann Pharmacother. 1995 Jul-Aug;29(7-8):743-59. doi: 10.1177/106002809502907-818.
引用本文的文献
1
The Statin Target HMG-Coenzyme a Reductase (Hmgcr) Regulates Sleep Homeostasis in .他汀类药物的靶点HMG辅酶A还原酶（Hmgcr）调节睡眠稳态。
Pharmaceuticals (Basel). 2022 Jan 10;15(1):79. doi: 10.3390/ph15010079.
2
Sleep changes following statin therapy: a systematic review and meta-analysis of randomized placebo-controlled polysomnographic trials.他汀类药物治疗后的睡眠变化：一项对随机安慰剂对照多导睡眠图试验的系统评价和荟萃分析。
Arch Med Sci. 2015 Oct 12;11(5):915-26. doi: 10.5114/aoms.2015.54841.
3
Statins, mood, sleep, and physical function: a systematic review.他汀类药物、情绪、睡眠与身体机能：一项系统综述
Eur J Clin Pharmacol. 2014 Dec;70(12):1413-22. doi: 10.1007/s00228-014-1758-y. Epub 2014 Oct 8.
4
Association of statin use with sleep disturbances: data mining of a spontaneous reporting database and a prescription database.他汀类药物使用与睡眠障碍的关联：对自发报告数据库和处方数据库的数据挖掘
Drug Saf. 2014 Jun;37(6):421-31. doi: 10.1007/s40264-014-0163-x.
5
Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management.他汀类药物相关的神经精神不良事件：流行病学、发病机制、预防和管理。
CNS Drugs. 2014 Mar;28(3):249-72. doi: 10.1007/s40263-013-0135-1.
6
How well tolerated are lipid-lowering drugs?降脂药物的耐受性如何？
Drugs Aging. 2001;18(9):665-83. doi: 10.2165/00002512-200118090-00003.
7
The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolaemia.辛伐他汀和普伐他汀对夜间睡眠客观及主观指标的影响：两种结构不同的HMG CoA还原酶抑制剂在原发性中度高胆固醇血症患者中的比较
Br J Clin Pharmacol. 1993 Mar;35(3):284-9.
8
Do cholesterol-lowering agents affect brain activity? A comparison of simvastatin, pravastatin, and placebo in healthy volunteers.降胆固醇药物会影响大脑活动吗？辛伐他汀、普伐他汀与安慰剂在健康志愿者中的比较。
Br J Clin Pharmacol. 1994 Mar;37(3):231-6. doi: 10.1111/j.1365-2125.1994.tb04268.x.
9
In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors.3-羟基-3-甲基戊二酰辅酶A（HMG-CoA）还原酶抑制剂的体内及体外血脑屏障转运
Pharm Res. 1994 Feb;11(2):305-11. doi: 10.1023/a:1018975928974.
10
Prediction of the therapeutic response to simvastatin by pretreatment lipid concentrations in 2082 subjects.根据2082名受试者治疗前的血脂浓度预测辛伐他汀的治疗反应。
Eur J Clin Pharmacol. 1994;46(2):107-14. doi: 10.1007/BF00199871.
本文引用的文献
1
3-Hydroxy-3-methylglutaryl--coenzyme A reductase inhibitors in the treatment of hypercholesterolemia.3-羟基-3-甲基戊二酰辅酶A还原酶抑制剂治疗高胆固醇血症
JAMA. 1987 Dec 25;258(24):3532-6.
2
HMG-CoA reductase inhibitors for hypercholesterolemia.用于治疗高胆固醇血症的HMG-CoA还原酶抑制剂。
N Engl J Med. 1988 Nov 3;319(18):1222-3. doi: 10.1056/NEJM198811033191811.
3
Topics in clinical pharmacology: lovastatin.临床药理学专题：洛伐他汀
Am J Med Sci. 1988 Dec;296(6):426-8. doi: 10.1097/00000441-198812000-00010.
Zotero 插件